Global Percutaneous Ventricular Assist Device Market Growth 2025-2031

June 2025 | 85 pages | ID: GA5327C3A1F1EN
LP Information

Abstracts

The global Percutaneous Ventricular Assist Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Percutaneous Ventricular Assist Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Percutaneous Ventricular Assist Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Percutaneous Ventricular Assist Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Percutaneous Ventricular Assist Device players cover Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Percutaneous Ventricular Assist Device Industry Forecast? looks at past sales and reviews total world Percutaneous Ventricular Assist Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Percutaneous Ventricular Assist Device sales for 2025 through 2031. With Percutaneous Ventricular Assist Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Percutaneous Ventricular Assist Device industry.

This Insight Report provides a comprehensive analysis of the global Percutaneous Ventricular Assist Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Percutaneous Ventricular Assist Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Percutaneous Ventricular Assist Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Percutaneous Ventricular Assist Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Percutaneous Ventricular Assist Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Percutaneous Ventricular Assist Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Impella CP
• Impella 5.1
• Impella LD

Segmentation by Application:

• Heart Failure
• Myocardial Infarction
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Johnson & Johnson

Key Questions Addressed in this Report
is the 10-year outlook for the global Percutaneous Ventricular Assist Device market?
factors are driving Percutaneous Ventricular Assist Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Percutaneous Ventricular Assist Device market opportunities vary by end market size?
How does Percutaneous Ventricular Assist Device break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Percutaneous Ventricular Assist Device Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Percutaneous Ventricular Assist Device by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Percutaneous Ventricular Assist Device by Country/Region, 2020, 2024 & 2031
2.2 Percutaneous Ventricular Assist Device Segment by Type
  2.2.1 Impella CP
  2.2.2 Impella 5.1
  2.2.3 Impella LD
2.3 Percutaneous Ventricular Assist Device Sales by Type
  2.3.1 Global Percutaneous Ventricular Assist Device Sales Market Share by Type (2020-2025)
  2.3.2 Global Percutaneous Ventricular Assist Device Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Percutaneous Ventricular Assist Device Sale Price by Type (2020-2025)
2.4 Percutaneous Ventricular Assist Device Segment by Application
  2.4.1 Heart Failure
  2.4.2 Myocardial Infarction
  2.4.3 Other
2.5 Percutaneous Ventricular Assist Device Sales by Application
  2.5.1 Global Percutaneous Ventricular Assist Device Sale Market Share by Application (2020-2025)
  2.5.2 Global Percutaneous Ventricular Assist Device Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Percutaneous Ventricular Assist Device Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Percutaneous Ventricular Assist Device Breakdown Data by Company
  3.1.1 Global Percutaneous Ventricular Assist Device Annual Sales by Company (2020-2025)
  3.1.2 Global Percutaneous Ventricular Assist Device Sales Market Share by Company (2020-2025)
3.2 Global Percutaneous Ventricular Assist Device Annual Revenue by Company (2020-2025)
  3.2.1 Global Percutaneous Ventricular Assist Device Revenue by Company (2020-2025)
  3.2.2 Global Percutaneous Ventricular Assist Device Revenue Market Share by Company (2020-2025)
3.3 Global Percutaneous Ventricular Assist Device Sale Price by Company
3.4 Key Manufacturers Percutaneous Ventricular Assist Device Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Percutaneous Ventricular Assist Device Product Location Distribution
  3.4.2 Players Percutaneous Ventricular Assist Device Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PERCUTANEOUS VENTRICULAR ASSIST DEVICE BY GEOGRAPHIC REGION

4.1 World Historic Percutaneous Ventricular Assist Device Market Size by Geographic Region (2020-2025)
  4.1.1 Global Percutaneous Ventricular Assist Device Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Percutaneous Ventricular Assist Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Percutaneous Ventricular Assist Device Market Size by Country/Region (2020-2025)
  4.2.1 Global Percutaneous Ventricular Assist Device Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Percutaneous Ventricular Assist Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Percutaneous Ventricular Assist Device Sales Growth
4.4 APAC Percutaneous Ventricular Assist Device Sales Growth
4.5 Europe Percutaneous Ventricular Assist Device Sales Growth
4.6 Middle East & Africa Percutaneous Ventricular Assist Device Sales Growth

5 AMERICAS

5.1 Americas Percutaneous Ventricular Assist Device Sales by Country
  5.1.1 Americas Percutaneous Ventricular Assist Device Sales by Country (2020-2025)
  5.1.2 Americas Percutaneous Ventricular Assist Device Revenue by Country (2020-2025)
5.2 Americas Percutaneous Ventricular Assist Device Sales by Type (2020-2025)
5.3 Americas Percutaneous Ventricular Assist Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Percutaneous Ventricular Assist Device Sales by Region
  6.1.1 APAC Percutaneous Ventricular Assist Device Sales by Region (2020-2025)
  6.1.2 APAC Percutaneous Ventricular Assist Device Revenue by Region (2020-2025)
6.2 APAC Percutaneous Ventricular Assist Device Sales by Type (2020-2025)
6.3 APAC Percutaneous Ventricular Assist Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Percutaneous Ventricular Assist Device by Country
  7.1.1 Europe Percutaneous Ventricular Assist Device Sales by Country (2020-2025)
  7.1.2 Europe Percutaneous Ventricular Assist Device Revenue by Country (2020-2025)
7.2 Europe Percutaneous Ventricular Assist Device Sales by Type (2020-2025)
7.3 Europe Percutaneous Ventricular Assist Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Percutaneous Ventricular Assist Device by Country
  8.1.1 Middle East & Africa Percutaneous Ventricular Assist Device Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Percutaneous Ventricular Assist Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Percutaneous Ventricular Assist Device Sales by Type (2020-2025)
8.3 Middle East & Africa Percutaneous Ventricular Assist Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Percutaneous Ventricular Assist Device
10.3 Manufacturing Process Analysis of Percutaneous Ventricular Assist Device
10.4 Industry Chain Structure of Percutaneous Ventricular Assist Device

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Percutaneous Ventricular Assist Device Distributors
11.3 Percutaneous Ventricular Assist Device Customer

12 WORLD FORECAST REVIEW FOR PERCUTANEOUS VENTRICULAR ASSIST DEVICE BY GEOGRAPHIC REGION

12.1 Global Percutaneous Ventricular Assist Device Market Size Forecast by Region
  12.1.1 Global Percutaneous Ventricular Assist Device Forecast by Region (2026-2031)
  12.1.2 Global Percutaneous Ventricular Assist Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Percutaneous Ventricular Assist Device Forecast by Type (2026-2031)
12.7 Global Percutaneous Ventricular Assist Device Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Information
  13.1.2 Johnson & Johnson Percutaneous Ventricular Assist Device Product Portfolios and Specifications
  13.1.3 Johnson & Johnson Percutaneous Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Johnson & Johnson Main Business Overview
  13.1.5 Johnson & Johnson Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Percutaneous Ventricular Assist Device Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Percutaneous Ventricular Assist Device Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Impella CP
Table 4. Major Players of Impella 5.1
Table 5. Major Players of Impella LD
Table 6. Global Percutaneous Ventricular Assist Device Sales by Type (2020-2025) & (K Units)
Table 7. Global Percutaneous Ventricular Assist Device Sales Market Share by Type (2020-2025)
Table 8. Global Percutaneous Ventricular Assist Device Revenue by Type (2020-2025) & ($ million)
Table 9. Global Percutaneous Ventricular Assist Device Revenue Market Share by Type (2020-2025)
Table 10. Global Percutaneous Ventricular Assist Device Sale Price by Type (2020-2025) & (US$/Unit)
Table 11. Global Percutaneous Ventricular Assist Device Sale by Application (2020-2025) & (K Units)
Table 12. Global Percutaneous Ventricular Assist Device Sale Market Share by Application (2020-2025)
Table 13. Global Percutaneous Ventricular Assist Device Revenue by Application (2020-2025) & ($ million)
Table 14. Global Percutaneous Ventricular Assist Device Revenue Market Share by Application (2020-2025)
Table 15. Global Percutaneous Ventricular Assist Device Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Percutaneous Ventricular Assist Device Sales by Company (2020-2025) & (K Units)
Table 17. Global Percutaneous Ventricular Assist Device Sales Market Share by Company (2020-2025)
Table 18. Global Percutaneous Ventricular Assist Device Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Percutaneous Ventricular Assist Device Revenue Market Share by Company (2020-2025)
Table 20. Global Percutaneous Ventricular Assist Device Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Percutaneous Ventricular Assist Device Producing Area Distribution and Sales Area
Table 22. Players Percutaneous Ventricular Assist Device Products Offered
Table 23. Percutaneous Ventricular Assist Device Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Percutaneous Ventricular Assist Device Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Percutaneous Ventricular Assist Device Sales Market Share Geographic Region (2020-2025)
Table 28. Global Percutaneous Ventricular Assist Device Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Percutaneous Ventricular Assist Device Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Percutaneous Ventricular Assist Device Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Percutaneous Ventricular Assist Device Sales Market Share by Country/Region (2020-2025)
Table 32. Global Percutaneous Ventricular Assist Device Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Percutaneous Ventricular Assist Device Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Percutaneous Ventricular Assist Device Sales by Country (2020-2025) & (K Units)
Table 35. Americas Percutaneous Ventricular Assist Device Sales Market Share by Country (2020-2025)
Table 36. Americas Percutaneous Ventricular Assist Device Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Percutaneous Ventricular Assist Device Sales by Type (2020-2025) & (K Units)
Table 38. Americas Percutaneous Ventricular Assist Device Sales by Application (2020-2025) & (K Units)
Table 39. APAC Percutaneous Ventricular Assist Device Sales by Region (2020-2025) & (K Units)
Table 40. APAC Percutaneous Ventricular Assist Device Sales Market Share by Region (2020-2025)
Table 41. APAC Percutaneous Ventricular Assist Device Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Percutaneous Ventricular Assist Device Sales by Type (2020-2025) & (K Units)
Table 43. APAC Percutaneous Ventricular Assist Device Sales by Application (2020-2025) & (K Units)
Table 44. Europe Percutaneous Ventricular Assist Device Sales by Country (2020-2025) & (K Units)
Table 45. Europe Percutaneous Ventricular Assist Device Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Percutaneous Ventricular Assist Device Sales by Type (2020-2025) & (K Units)
Table 47. Europe Percutaneous Ventricular Assist Device Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Percutaneous Ventricular Assist Device Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Percutaneous Ventricular Assist Device Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Percutaneous Ventricular Assist Device Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Percutaneous Ventricular Assist Device Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Percutaneous Ventricular Assist Device
Table 53. Key Market Challenges & Risks of Percutaneous Ventricular Assist Device
Table 54. Key Industry Trends of Percutaneous Ventricular Assist Device
Table 55. Percutaneous Ventricular Assist Device Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Percutaneous Ventricular Assist Device Distributors List
Table 58. Percutaneous Ventricular Assist Device Customer List
Table 59. Global Percutaneous Ventricular Assist Device Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Percutaneous Ventricular Assist Device Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Percutaneous Ventricular Assist Device Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Percutaneous Ventricular Assist Device Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Percutaneous Ventricular Assist Device Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Percutaneous Ventricular Assist Device Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Percutaneous Ventricular Assist Device Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Percutaneous Ventricular Assist Device Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Percutaneous Ventricular Assist Device Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Percutaneous Ventricular Assist Device Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Percutaneous Ventricular Assist Device Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Percutaneous Ventricular Assist Device Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Percutaneous Ventricular Assist Device Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Percutaneous Ventricular Assist Device Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Johnson & Johnson Basic Information, Percutaneous Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 74. Johnson & Johnson Percutaneous Ventricular Assist Device Product Portfolios and Specifications
Table 75. Johnson & Johnson Percutaneous Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Percutaneous Ventricular Assist Device
Figure 2. Percutaneous Ventricular Assist Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Percutaneous Ventricular Assist Device Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Percutaneous Ventricular Assist Device Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Percutaneous Ventricular Assist Device Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Percutaneous Ventricular Assist Device Sales Market Share by Country/Region (2024)
Figure 10. Percutaneous Ventricular Assist Device Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Impella CP
Figure 12. Product Picture of Impella 5.1
Figure 13. Product Picture of Impella LD
Figure 14. Global Percutaneous Ventricular Assist Device Sales Market Share by Type in 2025
Figure 15. Global Percutaneous Ventricular Assist Device Revenue Market Share by Type (2020-2025)
Figure 16. Percutaneous Ventricular Assist Device Consumed in Heart Failure
Figure 17. Global Percutaneous Ventricular Assist Device Market: Heart Failure (2020-2025) & (K Units)
Figure 18. Percutaneous Ventricular Assist Device Consumed in Myocardial Infarction
Figure 19. Global Percutaneous Ventricular Assist Device Market: Myocardial Infarction (2020-2025) & (K Units)
Figure 20. Percutaneous Ventricular Assist Device Consumed in Other
Figure 21. Global Percutaneous Ventricular Assist Device Market: Other (2020-2025) & (K Units)
Figure 22. Global Percutaneous Ventricular Assist Device Sale Market Share by Application (2024)
Figure 23. Global Percutaneous Ventricular Assist Device Revenue Market Share by Application in 2025
Figure 24. Percutaneous Ventricular Assist Device Sales by Company in 2025 (K Units)
Figure 25. Global Percutaneous Ventricular Assist Device Sales Market Share by Company in 2025
Figure 26. Percutaneous Ventricular Assist Device Revenue by Company in 2025 ($ millions)
Figure 27. Global Percutaneous Ventricular Assist Device Revenue Market Share by Company in 2025
Figure 28. Global Percutaneous Ventricular Assist Device Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Percutaneous Ventricular Assist Device Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Percutaneous Ventricular Assist Device Sales 2020-2025 (K Units)
Figure 31. Americas Percutaneous Ventricular Assist Device Revenue 2020-2025 ($ millions)
Figure 32. APAC Percutaneous Ventricular Assist Device Sales 2020-2025 (K Units)
Figure 33. APAC Percutaneous Ventricular Assist Device Revenue 2020-2025 ($ millions)
Figure 34. Europe Percutaneous Ventricular Assist Device Sales 2020-2025 (K Units)
Figure 35. Europe Percutaneous Ventricular Assist Device Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Percutaneous Ventricular Assist Device Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Percutaneous Ventricular Assist Device Revenue 2020-2025 ($ millions)
Figure 38. Americas Percutaneous Ventricular Assist Device Sales Market Share by Country in 2025
Figure 39. Americas Percutaneous Ventricular Assist Device Revenue Market Share by Country (2020-2025)
Figure 40. Americas Percutaneous Ventricular Assist Device Sales Market Share by Type (2020-2025)
Figure 41. Americas Percutaneous Ventricular Assist Device Sales Market Share by Application (2020-2025)
Figure 42. United States Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Percutaneous Ventricular Assist Device Sales Market Share by Region in 2025
Figure 47. APAC Percutaneous Ventricular Assist Device Revenue Market Share by Region (2020-2025)
Figure 48. APAC Percutaneous Ventricular Assist Device Sales Market Share by Type (2020-2025)
Figure 49. APAC Percutaneous Ventricular Assist Device Sales Market Share by Application (2020-2025)
Figure 50. China Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 54. India Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Percutaneous Ventricular Assist Device Sales Market Share by Country in 2025
Figure 58. Europe Percutaneous Ventricular Assist Device Revenue Market Share by Country (2020-2025)
Figure 59. Europe Percutaneous Ventricular Assist Device Sales Market Share by Type (2020-2025)
Figure 60. Europe Percutaneous Ventricular Assist Device Sales Market Share by Application (2020-2025)
Figure 61. Germany Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 62. France Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Percutaneous Ventricular Assist Device Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Percutaneous Ventricular Assist Device Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Percutaneous Ventricular Assist Device Sales Market Share by Application (2020-2025)
Figure 69. Egypt Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Percutaneous Ventricular Assist Device Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Percutaneous Ventricular Assist Device in 2025
Figure 75. Manufacturing Process Analysis of Percutaneous Ventricular Assist Device
Figure 76. Industry Chain Structure of Percutaneous Ventricular Assist Device
Figure 77. Channels of Distribution
Figure 78. Global Percutaneous Ventricular Assist Device Sales Market Forecast by Region (2026-2031)
Figure 79. Global Percutaneous Ventricular Assist Device Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Percutaneous Ventricular Assist Device Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Percutaneous Ventricular Assist Device Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Percutaneous Ventricular Assist Device Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Percutaneous Ventricular Assist Device Revenue Market Share Forecast by Application (2026-2031)